Skip to main content
Journal ArticleOPEN ACCESS

Larotrectinib in a NTRK-rearranged soft tissue sarcoma in the neoadjuvant setting: A case report

Clinical Case Reports (2021) 9(3) 1694-1698
DOI: 10.1002/ccr3.3878
5Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Patients with soft tissue sarcomas should be assessed for neurotrophic tropomyosin receptor kinase (NTRK) gene fusions as neoadjuvant treatment with larotrectinib may prevent amputation.

Author supplied keywords

Cite

CITATION STYLE

APA

Percy, C., Schubert, T., Galant, C., Kirchgesner, T., & Mazzeo, F. (2021). Larotrectinib in a NTRK-rearranged soft tissue sarcoma in the neoadjuvant setting: A case report. Clinical Case Reports, 9(3), 1694–1698. https://doi.org/10.1002/ccr3.3878

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free